KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Long-Term Investments (2021 - 2025)

Twist Bioscience (TWST) has disclosed Long-Term Investments for 4 consecutive years, with $54.3 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments changed N/A to $54.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $54.3 million for FY2025, 3463.08% up from the prior year.
  • Long-Term Investments for Q4 2025 was $54.3 million at Twist Bioscience, roughly flat from $54.3 million in the prior quarter.
  • The five-year high for Long-Term Investments was $106.8 million in Q4 2021, with the low at $1.5 million in Q3 2024.
  • Average Long-Term Investments over 4 years is $50.3 million, with a median of $54.3 million recorded in 2025.
  • Peak annual rise in Long-Term Investments hit 3463.08% in 2025, while the deepest fall reached 3463.08% in 2025.
  • Over 4 years, Long-Term Investments stood at $106.8 million in 2021, then crashed by 71.37% to $30.6 million in 2022, then tumbled by 95.01% to $1.5 million in 2024, then surged by 3463.08% to $54.3 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $54.3 million, $54.3 million, and $54.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.